0A0L Stock Overview Provides solutions for medical IT and cybersecurity sectors in Sweden, the United Kingdom, the Netherlands, and rest of Europe. More details
Rewards Risk Analysis 0A0L passed our risk checks.
See All Risk Checks Capture your thoughts, links and company narrative
Add noteSectra AB (publ) Competitors Price History & Performance
Summary of share price highs, lows and changes for Sectra Historical stock prices Current Share Price SEK 275.05 52 Week High SEK 300.20 52 Week Low SEK 164.00 Beta 1.24 1 Month Change 0.18% 3 Month Change 4.50% 1 Year Change 58.58% 3 Year Change 39.92% 5 Year Change 248.30% Change since IPO 2,148.64%
Recent News & Updates
High number of new directors Oct 20
Insider recently sold kr3.4m worth of stock Oct 06
First quarter 2025 earnings released: EPS: kr0.42 (vs kr0.32 in 1Q 2024) Sep 06
Full year 2024 earnings released: EPS: kr2.22 (vs kr1.95 in FY 2023) Jul 05 Sectra AB (publ) to Report Fiscal Year 2025 Results on Jun 05, 2025 Jun 06
New major risk - Earnings quality Jun 06 See more updates
High number of new directors Oct 20
Insider recently sold kr3.4m worth of stock Oct 06
First quarter 2025 earnings released: EPS: kr0.42 (vs kr0.32 in 1Q 2024) Sep 06
Full year 2024 earnings released: EPS: kr2.22 (vs kr1.95 in FY 2023) Jul 05 Sectra AB (publ) to Report Fiscal Year 2025 Results on Jun 05, 2025 Jun 06
New major risk - Earnings quality Jun 06
Sectra Adds It Solution for Genomics in Cancer Diagnostics-First Deployment At A Us Health System Jun 05
Sectra and Leica Biosystems Gains FDA Clearance to Utilize DICOM Images for Pathology Diagnostics Apr 30 Sectra AB (publ) to Report Nine Months, 2025 Results on Mar 14, 2025
Third quarter 2024 earnings released: EPS: kr0.30 (vs kr0.38 in 3Q 2023) Mar 09
Sectra AB (publ) to Report Q1, 2025 Results on Sep 06, 2024 Mar 08
Chief People & Brand Officer recently sold kr390k worth of stock Feb 03
Insider recently sold kr1.8m worth of stock Jan 25
Investor sentiment improves as stock rises 19% Dec 22
Sectra AB (publ), Annual General Meeting, Sep 10, 2024 Dec 21
New major risk - Earnings quality Dec 16
Second quarter 2024 earnings released: EPS: kr0.78 (vs kr0.49 in 2Q 2023) Dec 16
New minor risk - Share price stability Nov 15
First quarter 2024 earnings released Sep 06
Full year 2023 earnings released: EPS: kr1.95 (vs kr1.63 in FY 2022) Jul 07
Sectra AB (Publ) Proposes Dividend Jun 03
Full year 2023 earnings released: EPS: kr1.95 (vs kr1.63 in FY 2022) Jun 02
High number of new directors Mar 30
Sectra AB (publ), Annual General Meeting, Sep 07, 2023 Dec 20
Investor sentiment improved over the past week Sep 23
Sectra AB (Publ) Elects Ulrika Unell to the Board Sep 09
First quarter 2023 earnings released Sep 03
Sectra Launches Next Generation Cloud Portal to Enhance Clinical Learning in Medical Education Aug 16
Full year 2022 earnings released: EPS: kr1.63 (vs kr1.43 in FY 2021) Jul 08
Investor sentiment improved over the past week Jun 17
Full year 2022 earnings released: EPS: kr1.63 (vs kr1.43 in FY 2021) Jun 04
Sectra AB (Publ) Proposes Dividend Jun 03
Investor sentiment improved over the past week May 27
Investor sentiment improved over the past week May 09 Sectra AB (publ) to Report Nine Months, 2023 Results on Mar 10, 2023
High number of new directors Apr 27
Third quarter 2022 earnings: Revenues exceed analyst expectations Mar 10
Investor sentiment improved over the past week Mar 09
Independent Director recently bought kr932k worth of stock Dec 16
Independent Director recently bought kr932k worth of stock Dec 16
Second quarter 2022 earnings: Revenues miss analyst expectations Dec 12
High number of new directors Dec 11
High number of new directors Oct 31
First quarter 2022 earnings released: EPS kr1.90 (vs kr0.44 in 1Q 2021) Sep 05
Full year 2021 earnings released: EPS kr7.15 (vs kr6.18 in FY 2020) Jul 04
Full year 2021 earnings released: EPS kr7.15 (vs kr6.18 in FY 2020) Jun 04
Chief Financial Officer recently bought kr123k worth of stock Mar 16
New 90-day low: kr614 Mar 16
Third quarter 2021 earnings released: EPS kr1.39 (vs kr2.06 in 3Q 2020) Mar 14
Revenue misses expectations Mar 14
Sectra Signs Five-Year Enterprise Imaging Contract with Emory Healthcare in the US Mar 12
Quantum-Proof Crypto from Sectra Receives SECRET Approval from EU Mar 10 Sectra AB (publ) to Report Fiscal Year 2022 Results on Jun 03, 2022
EU Orders Sectra Tiger Solution for Sharing Classified Information Feb 10
Sectra AB (Publ) Receives an Order for its Digital Pathology Solution from Amsterdam UMC in the Netherlands Jan 22
Sectra Receives Order from Institut Bergonié Jan 20
Healthcare Region Pioneering Digital Pathology Reviews in Denmark with Sectra-Aims to Significantly Shorten Cancer Turn-Around Times Jan 14
The Pennine Acute Hospitals NHS Trust Deploys the Imaging IT Solution from Sectra Jan 12
New 90-day high: kr759 Dec 24
Norwegian Healthcare Region Appoints Sectra as Enterprise Imaging Vendor for Efficient Region-Wide Patient Care Dec 12
Insider recently bought kr103k worth of stock Dec 04
Sectra Signs Subscription-Based Enterprise Imaging Contract with Dayton Children's Hospital in US Dec 04
Sectra and RSA Biomedical sign distribution agreement for Sectra's CT-based method for clinical validation of orthopaedic implant stability Dec 02
New 90-day high: kr690 Dec 02
Revenue beats expectations Nov 28
Second quarter 2021 earnings released: EPS kr1.89 Nov 28
Sectra to Add its Digital Pathology Module to the Sectra Enterprise Imaging Solution Nov 17
Sectra Signs A Digital Pathology Contract with the Helse Vest Nov 12
Sectra Deploys Its Software for Medical Imaging At Leeds Teaching Hospitals Nov 09
Sectra's Digital Pathology Solution Used in Training of Pathologists in Australasia Nov 07
New 90-day low: kr534 Oct 31
Amsterdam UMC Chooses Sectra for Enterprise-Wide Radiology Imaging Oct 19
Chief People & Brand Officer recently bought kr62k worth of stock Oct 14
Sectra and Greater Manchester Sign Deal for One of the Largest Region-Wide Imaging Initiatives in Europe Oct 05
Sectra Signs Enterprise Imaging Contracts with Two Top-Rated Health Systems in US Sep 17
First quarter earnings released Sep 09
New 90-day high - kr641 Sep 01
New 90-day high - kr622 Aug 05 Shareholder Returns 0A0L GB Healthcare Services GB Market 7D 3.4% -1.5% -0.6% 1Y 58.6% 15.7% 3.1%
See full shareholder returns
Return vs Market: 0A0L exceeded the UK Market which returned 2.6% over the past year.
Price Volatility Is 0A0L's price volatile compared to industry and market? 0A0L volatility 0A0L Average Weekly Movement 3.8% Healthcare Services Industry Average Movement 6.1% Market Average Movement 4.8% 10% most volatile stocks in GB Market 10.6% 10% least volatile stocks in GB Market 2.6%
Stable Share Price: 0A0L has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0A0L's weekly volatility (4%) has been stable over the past year.
About the Company Founded Employees CEO Website 1957 1,224 Torbjörn Kronander sectra.com
Sectra AB (publ) provides solutions for medical IT and cybersecurity sectors in Sweden, the United Kingdom, the Netherlands, and rest of Europe. The company operates through Imaging IT Solutions, Secure Communications, and Business Innovation segments. The Imaging IT Solutions segment develops and sells medical IT systems and services for managing, archiving, and presenting various types of medical images and patient information, as well as for operational follow-up and radiation dose monitoring; maintenance services in the form of support and system monitoring; and consulting services related to integration, system design, data migration, and business development.
Show more Sectra AB (publ) Fundamentals Summary How do Sectra's earnings and revenue compare to its market cap? 0A0L fundamental statistics Market cap SEK 52.99b Earnings (TTM ) SEK 384.43m Revenue (TTM ) SEK 3.14b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 0A0L income statement (TTM ) Revenue SEK 3.14b Cost of Revenue SEK 1.99b Gross Profit SEK 1.15b Other Expenses SEK 767.36m Earnings SEK 384.43m
Last Reported Earnings
Oct 31, 2024
Next Earnings Date
Mar 14, 2025
Earnings per share (EPS) 2.00 Gross Margin 36.71% Net Profit Margin 12.25% Debt/Equity Ratio 0%
How did 0A0L perform over the long term?
See historical performance and comparison Dividends
0.4% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/24 09:12 End of Day Share Price 2024/12/23 00:00 Earnings 2024/10/31 Annual Earnings 2024/04/30
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Sectra AB (publ) is covered by 11 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution null null ABG Sundal Collier Bjorn Rydell ABG Sundal Collier Sponsored Mikael Löfdahl Carnegie Investment Bank AB
Show 8 more analysts